Skip to main content

Ultra-fast Antimicrobial Susceptibility Test for diagnosing antimicrobial resistance to provide personalized antibiotic treatments

Project description

A novel analysis platform could find the silver bullet against an infection within hours

Bacteria are literally everywhere and the 'bad' ones are on the rise, developing resistance to antimicrobial drugs and flourishing in the face of years of pharmaceutical development aimed at protecting us. The types and doses of antibiotics have increased in response. Yet, prescribing the 'silver bullet' remains complicated by the lack of rapid diagnostic methods seeking to determine which antibiotic works best against the microbe that has caused the infection. Some of the most insidious infections result in an almost trial-and-error approach in which patients may have their treatments changed only when the chosen one is shown to be ineffective, sometimes after several days of therapy. The EU-funded Nanosynex project is bringing a same-day solution to market in the form of a table-top test platform with appropriate analysis software. Widespread use could enable personalised antibiotic therapy, an important weapon against growing antimicrobial resistance.

Call for proposal

H2020-EIC-SMEInst-2018-2020-3
See other projects for this call

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)

Coordinator

NANOSYNEX LTD
Address
Metsada 7 St
5126112 Bnei Brak
Israel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 2 562 875